Biomolecular network-based synergistic drug combination discovery: a combination of paeoniflorin and liquiritin alleviates neuropathic pain by inhibiting neuroinflammation via suppressing the chemokine signaling pathway

Signal Transduct Target Ther. 2020 May 22;5(1):73. doi: 10.1038/s41392-020-0160-8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chemokines / metabolism*
  • Disease Models, Animal
  • Drug Discovery*
  • Drug Therapy, Combination
  • Flavanones / pharmacology*
  • Glucosides / pharmacology*
  • Humans
  • Monoterpenes / pharmacology*
  • Neuralgia* / drug therapy
  • Neuralgia* / metabolism
  • Neuralgia* / pathology
  • Rats
  • Signal Transduction / drug effects*

Substances

  • Chemokines
  • Flavanones
  • Glucosides
  • Monoterpenes
  • peoniflorin
  • liquiritin